1. Home
  2. PGEN vs CIVB Comparison

PGEN vs CIVB Comparison

Compare PGEN & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • CIVB
  • Stock Information
  • Founded
  • PGEN 1998
  • CIVB 1884
  • Country
  • PGEN United States
  • CIVB United States
  • Employees
  • PGEN N/A
  • CIVB N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • CIVB Major Banks
  • Sector
  • PGEN Health Care
  • CIVB Finance
  • Exchange
  • PGEN Nasdaq
  • CIVB Nasdaq
  • Market Cap
  • PGEN 292.6M
  • CIVB 274.6M
  • IPO Year
  • PGEN N/A
  • CIVB N/A
  • Fundamental
  • Price
  • PGEN $0.90
  • CIVB $22.54
  • Analyst Decision
  • PGEN Buy
  • CIVB Buy
  • Analyst Count
  • PGEN 5
  • CIVB 4
  • Target Price
  • PGEN $7.00
  • CIVB $19.67
  • AVG Volume (30 Days)
  • PGEN 858.0K
  • CIVB 72.4K
  • Earning Date
  • PGEN 11-14-2024
  • CIVB 10-29-2024
  • Dividend Yield
  • PGEN N/A
  • CIVB 2.83%
  • EPS Growth
  • PGEN N/A
  • CIVB N/A
  • EPS
  • PGEN N/A
  • CIVB 2.00
  • Revenue
  • PGEN $3,963,000.00
  • CIVB $146,565,000.00
  • Revenue This Year
  • PGEN N/A
  • CIVB N/A
  • Revenue Next Year
  • PGEN $211.35
  • CIVB $6.04
  • P/E Ratio
  • PGEN N/A
  • CIVB $11.19
  • Revenue Growth
  • PGEN N/A
  • CIVB N/A
  • 52 Week Low
  • PGEN $0.77
  • CIVB $13.60
  • 52 Week High
  • PGEN $1.93
  • CIVB $23.70
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 52.02
  • CIVB 69.71
  • Support Level
  • PGEN $0.77
  • CIVB $21.78
  • Resistance Level
  • PGEN $1.05
  • CIVB $23.01
  • Average True Range (ATR)
  • PGEN 0.07
  • CIVB 0.80
  • MACD
  • PGEN -0.00
  • CIVB -0.07
  • Stochastic Oscillator
  • PGEN 47.46
  • CIVB 66.86

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

Share on Social Networks: